Clinical Trial

CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)

Study acronym: CARMEN-CHF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Study aims to investigate the incidence, associations and prognostic value of CRGM and its components: chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease in patients with different phenotypes and severity of clinical manifestations of CHF.
Trial Details
NCT Number NCT07380828
Lead Sponsor Russian Scientific Medical Society of Therapists
Conditions Heart Failure, Cardio-renal-metabolic Syndrome
Enrollment 3,000 participants
Start Date 2026-02
Primary Completion 2029-04 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-02